References
- Bodanszky M, Martinez J, Priestly GP, Gardner JD, Mutt V. 1978. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate. J Med Chem; 21: 1030–1035.
- Dreyfuss P. 1974. Synthesis and some pharmacological properties of 8-ε-hydroxynorleucine-vasopressin. J Med Chem; 17: 252–255.
- Hanson R, Schwinden MD, Banerjee A, Brzozowski D, Chen BC, Patel BP, . 1999. Enzymatic synthesis of L-6-hydroxynorleucine. Bioorg Med Chem; 7: 2247–2252.
- Hong EY, Cha M, Yun H, Kim BG. 2010. Asymmetric synthesis of l-tert-leucine and l-3-hydroxyadamantylglycine using branched chain aminotransferase. J Mol Catal B-Enzym; 66: 228–233.
- Hwang BY, Cho BK, Yun H, Koteshwar K, Kim BG. 2005. Revisit of aminotransferase in the genomic era and its application to biocatalysis. J Mol Catal B-Enzym; 37: 47–55.
- Kaufman S, Mason K. 1982. Specificity of amino acids as activators and substrates for phenylalanine hydroxylase. J Biol Chem; 257: 14667–14678.
- Kern BA, Reitz RH. 1978. A general method for the preparation of the D- or L-stereoisomers of 5-substituted hydantoins. Agric Biol Chem; 42: 1275–1278.
- Li T, Kootstra AB, Fotheringham IG. 2002. Nonproteinogenic α-amino acid preparation using equilibrium shifted transamination. Org Proc Res Dev; 6: 533–538.
- Maurer PJ, Miller MJ. 1981. Mycobactins: synthesis of (−)-cobaltin T from ε-hydroxynorleucine. J Org Chem; 46: 2835–2836.
- Maurer PJ, Miller MJ. 1982. Microbial iron chelators—total synthesis of aerobactin and its constituent amino acid, N6-acetyl-N6-hydroxylysine. J Am Chem Soc; 104: 3096–3101.
- Maurer PJ, Miller MJ. 1983. Total synthesis of a mycobactin: mycobactin S2. J Am Chem Soc; 105: 240–245.
- Morales O, Seide W, Watson SE. 2006. Synthesis of 7,6-fused bicyclic lactams for use as beta-turn mimics. Synth Commun; 36: 965–973.
- Patel RN. 2001. Enzymatic synthesis of chiral intermediates for Omapatrilat, an antihypertensive drug. Biomol Eng; 17: 167–182.
- Robl JA, Cimarusti MP. 1994. A synthetic route for the generation of C-7 substituted azepinones. Tetrahedron Lett; 35: 1393–1396.
- Robl JA, Sun C, Stevenson J, Ryono DE, Simpkins LM, Cimarusti MA, . 1997. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. J Med Chem; 40: 1570–1577.
- Steward JD. 2001. Dehydrogenases and transaminases in asymmetric synthesis. Curr Opin Chem Biol; 5: 120–129.
- Taylor PP, Pantaleone DP, Senkpeil RF, Fotheringham IG. 1998. Novel biosynthetic approaches to the production of unnatural amino acids using transaminases. Trends Biotechnol; 16: 412–418.
- Yun H, Hwang BY, Lee JH, Kim BG. 2005. Use of enrichment culture for directed evolution of the Vibrio fluvialis JS17 ω-transaminase, which is resistant to product inhibition by aliphatic ketones. Appl Environ Microbiol; 71: 4220–4224.
- Yun H, Kim BG. 2008. Enzymatic production of -phenylacetylcarbinol by pyruvate decarboxylase from Zymomonas mobilis. Biotechnol Bioprocess Eng; 13: 372–376.
- Zhu D, Hua L. 2009. Biocatalytic asymmetric amination of carbonyl functional groups – a synthetic biology approach to organic chemistry. Biotechnol J; 4: 1420–1431.